New York Life Investment Management’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-91,499
Closed -$22.6M 768
2025
Q3
$22.6M Sell
91,499
-2,385
-3% -$622K 0.2% 96
2025
Q2
$28.1M Buy
93,884
+1,311
+1% +$399K 0.26% 75
2025
Q1
$28.9M Sell
92,573
-328
-0.4% -$116K 0.29% 65
2024
Q4
$32.7M Sell
92,901
-920
-1% -$331K 0.32% 50
2024
Q3
$33.2M Sell
93,821
-996
-1% -$328K 0.32% 57
2024
Q2
$28.8M Sell
94,817
-374
-0.4% -$115K 0.29% 62
2024
Q1
$33M Sell
95,191
-3,779
-4% -$1.38M 0.33% 55
2023
Q4
$34.7M Sell
98,970
-8,008
-7% -$2.58M 0.36% 51
2023
Q3
$32.9M Sell
106,978
-1,907
-2% -$601K 0.36% 50
2023
Q2
$33.6M Sell
108,885
-646
-0.6% -$188K 0.35% 51
2023
Q1
$31.3M Buy
109,531
+9,662
+10% +$2.63M 0.35% 50
2022
Q4
$26.6M Sell
99,869
-173
-0.2% -$47.9K 0.3% 60
2022
Q3
$25.7M Sell
100,042
-119
-0.1% -$34.4K 0.31% 61
2022
Q2
$27.8M Buy
+100,161
New +$30.1M 0.32% 59

Other funds holding ACN

New York Life Investment Management's ACN Position: Q4 2025 in Review

New York Life Investment Management sold out of Accenture (ACN) in Q4 2025, closing a stake of 91,499 shares — an estimated $22.6M sold.

New York Life Investment Management first reported a position in ACN in Q2 2022 and held it in 14 quarters. The position peaked at $34.7M in Q4 2023. 2,363 funds tracked by Wall St. Rank hold ACN as of Q4 2025.

  • New York Life Investment Management reported no remaining Accenture position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 91,499 Accenture shares in Q4 2025, an estimated $22.6M.
  • New York Life Investment Management first reported a position in Accenture in Q2 2022 and held it in 14 quarters.
  • New York Life Investment Management's Accenture position peaked at $34.7M in Q4 2023.
  • 2,363 funds tracked by Wall St. Rank held Accenture as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.